{"id":273438,"date":"2026-09-28T10:23:06","date_gmt":"2026-09-28T04:53:06","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=273438"},"modified":"2026-09-28T10:23:06","modified_gmt":"2026-09-28T04:53:06","slug":"hester-biosciences-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/hester-biosciences-best-stock-in-its-sector\/","title":{"rendered":"Is Hester Biosciences the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Hester Biosciences CMP Rs 2,165 (28 Sep 2026). Market cap Rs 1,858 Cr. ROE 15.45%. P\/E 13.57x versus Industry P\/E 38.42x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Hester Biosciences is one of the names investors compare when screening the Healthcare sector, built on a 15.45% return on equity and a P\/E of 13.57x against an Industry P\/E of 38.42x. Whether Hester Biosciences is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Hester Biosciences<\/a> the best stock in its sector? The stock trades on the NSE at Rs 2,165 as of 28 September 2026, within its 52-week range of Rs 1,239.30 to Rs 2,683.60. Hester Biosciences Ltd makes poultry and livestock vaccines and animal health products.<\/p>\n

Hester Biosciences sits in the Healthcare sector, and its 15.45% ROE and 13.57x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n